Research Article
Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous
Table 3
(a) Chemokines levels in vitreous. (b) Growth factors levels in vitreous.
| (a) |
| | Chemokines | Non-PDR
| PDR
| Mann-Whitney test |
| | CCL2/MCP-1 median (range) | 1537 (902.07–3341) | 7619.5 (3048–12191) | | | CCL4/MIP-1 median (range) | 17.86 (8.48–28.23) | 23.22 (12.02–72.28) | | | CCL11 median (range) | 12.15 (4.62–18.84) | 15.15 (7.72–44.61) | | | CCL17 median (range) | ND | 2.14 (0–6.02) | | | CCL19 median (range) | 41 (0–115) | 219.67 (35.10–915.66) | | | CXCL9 median (range) | 200.44 (75.1–898.24) | 1230.99 (340.37–10790) | | | CXCL10 median (range) | 284.82 (188.84–804.72) | 1283 (327.13–15132) | |
|
|
| (b) |
| | Growth factors | Non-PDR
| PDR
| Mann-Whitney test |
| | VEGF median (range) | 184.07 (51.54–273.39) | 572.12 (221.54–5533) | | | TGF1 median (range) | 16.71 (0–38.27) | 157.98 (38.27–464.63) | | | TGF2 median (range) | 7384.5 (4692–12261) | 10743.5 (7347–19061) | | | TGF3 median (range) | 37.49 (25.19–45.28) | 43.02 (11.81–103.03) | |
|
|
ND: not detected.
|
